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and Mariano A. Garcia-Blanco2,3
Synthesis of collagen, a major component of the extracellular matrix, is increased dramatically in fibrotic
conditions such as scleroderma. This overaccumulation of collagen is associated with increased pyridinoline
cross-links. These cross-links are derived by the action of the alternatively spliced long form of lysyl hydroxylase
2 (LH2), a collagen telopeptide LH. As LH2 (long) is reported to be overexpressed in scleroderma fibroblasts, the
regulation of LH2 splicing suggests an important step in controlling fibrosis. Using an LH2 minigene, we have
compared the regulation of the alternative splicing pattern of LH2, both endogenously and in the minigene, by
the RNA-binding splicing proteins TIA-1 and TIAL1 (T-cell-restricted intracellular antigens). A decrease in the
ratio of LH2 (long) to LH2 (short) was observed in fibroblasts from TIAL1 knockout mice, and in HEK293 cells
knocked down for TIA-1 and TIAL1. As a corollary, overexpression of TIA-1/TIAL1 in HEK293 cells resulted in an
increase in LH2 (long) minigene transcripts, accompanied by a decrease in LH2 (short). In scleroderma
fibroblasts, a double TIA-1/TIAL1 knockdown reduced the ratio of LH2 (long) to LH2 (short) by over fivefold
compared to controls. Identification of these TIA regulatory factors therefore suggests a tool to manipulate
cellular LH2 levels in scleroderma so that potential intervention therapies may be identified.
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INTRODUCTION
The lysyl hydroxylases (LH1, LH2, and LH3; also described as
PLOD1, 2, and 3; procollagen lysine oxoglutarate dehydro-
genases) constitute a family of posttranslational modifying
enzymes that provide a crucial hydroxylation step in collagen
biosynthesis (Yeowell, 2002). The individual LHs appear to
have specificity, either in the helical or nonhelical (telopeptide)
domain, for the hydroxylation of collagen lysines (Mercer et al.,
2003; van der Slot et al., 2003). The telopeptide hydroxylysines
are the precursors for the type of collagen cross-linking that
gives collagen its tensile strength. Collagen cross-links can be
formed via two major related routes: the allysine route in which
the cross-link is formed from telopeptide lysine and the
hydroxyallysine route in which the cross-link is formed from
telopeptide hydroxylysine. Bifunctional cross-links derived
from the allysine route mature into the trifunctional cross-link
histidinohydroxylysinonorleucine (Yamauchi et al., 1987)
whereas the bifunctional cross-links formed via the hydro-
xyallysine route mature into the trifunctional cross-links,
pyridinoline (Pyr) or deoxypyridinoline (Dpyr).
LH2 is the first LH isoform in which alternative splicing has
been reported (Yeowell and Walker, 1999). The short isoform
was isolated from human kidney and pancreas cDNA libraries
(Valtavaara et al., 1997); the alternatively spliced long form
was identified later in skin fibroblast cDNA (Yeowell and
Walker, 1999). The long form of LH2, which contains an
additional 63 bp exon (exon 13A), is the major transcript and is
expressed in all tissues examined to date. LH2 (short) is
expressed in spleen, kidney, liver, and placenta and, in
untreated tissues, is always accompanied by expression of the
long form. As these alternatively spliced LH2 isoforms appear
to have specificity for hydroxylation of lysines in either
telopeptide or helical collagen domains, their relative expres-
sion determines the type of cross-links formed (van der Slot-
Verhoeven et al., 2005). LH2 (long) has been proposed as the
collagen telopeptide LH that is linked to Pyr cross-linking (van
der Slot et al., 2004; Takaluoma et al., 2007).
The pattern of alternative splicing in the LH2 gene appears
to contribute significantly to fibrotic conditions such as
scleroderma. The excessive accumulation of collagen that is
a characteristic of scleroderma is accompanied by a change
in the pattern of collagen cross-links with an increase in the
level of Pyr cross-links. The increased Pyr cross-links (van der
Slot et al., 2005) and the precursor bifunctional cross-links
formed via the hydroxyallysine route (Brinckmann et al.,
2005) that are observed in scleroderma and other fibrotic
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conditions such as keloids, activated hepatic stellate cells,
hypertrophic scarring, scar formation in deep dermal
wounds, and palmar fascia of Dupuytren’s patients (van der
Slot et al., 2004; Ulrich et al., 2007) parallel the reported
increase in LH2 (long) under these conditions. Consequently,
studies on the mechanism and regulation of LH2 splicing
become very important to enhance our basic understanding
of the molecular mechanism of fibrotic diseases.
In this article we report on the development of a viable LH2
minigene which we used to examine the alternative splicing of
LH2 transcripts in three cell types: human neonatal skin
fibroblasts and mouse embryonic fibroblasts (MEFs; in which
the LH2 (long) spliced form predominates), and in human
embryonic kidney cells (in which both LH2 (long) and (short)
are expressed). A phylogenetic analysis of the sequences
flanking exon 13A led us to investigate the role that the TIA
(T-cell-restricted intracellular antigen) family of splicing factors
plays in the regulation of the LH2 alternate splicing event (Le
Guiner et al., 2001). This analysis revealed that exon 13A has
an evolutionarily conserved nonconsensus downstream 50
splice site flanked by a U-rich region that is characteristic of
alternative splicing regulatory elements in other exons/introns
that recruit the TIA family of nuclear proteins. These proteins,
which include TIA-1 and the TIA-1-like protein TIAL1, (also
referred to as TIAR), play an important role in the regulation of
alternate splicing by strengthening weak 50 splice sites that do
not conform to the consensus splice sequence (Le Guiner et al.,
2001; McAlinden et al., 2007).
Utilizing the functional LH2 minigene, we show that the
TIA proteins play a role in the regulation of the alternative
splicing of LH2. The reduction of TIA protein levels in MEFs
and HEK293 cells led to a corresponding decrease in the LH2
(long) spliced product in both the minigene and the
endogenous gene. Furthermore, overexpression of the TIA
proteins in HEK293 cells led to an increase in levels of the
LH2 (long) spliced product in the minigene. Results from an
initial study on the effect of these factors in scleroderma cells
indicate that reduction of TIAs significantly decreases LH2
(long). Although differential expression of LH2 (long) is
associated with fibrotic conditions, there is no direct
evidence that the increased Pyr cross-links in the over-
accumulated collagen contribute definitively to fibrosis.
Identification of these regulatory factors therefore provides a
tool to manipulate spliced LH2 levels so that their individual
roles may be clearly established and that potential interven-
tion therapies may be identified.
RESULTS
Exon 13A and flanking introns are highly conserved across
species
The endogenous splicing pattern of LH2 transcripts is dia-
grammed in the top panel of Figure 1 which illustrates either the
inclusion of exon 13A (to give the long form of LH2) or the
exclusion of exon 13A (to give the short form of LH2). To
identify cis-acting elements that may regulate this alternative
splicing event, we performed a phylogenetic analysis that
enabled us to identify the evolutionarily conserved intronic
splicing regulatory elements (Figure 1). Using the MacVector
Clustal W alignment function (Higgins et al., 1996; Mistry et al.,
2003), we aligned the alternatively spliced exon 13A and
200–300 bases of flanking introns 13 and 13A from six different
vertebrate species. This program revealed the high conservation
of exon 13A across vertebrate species and also the conservation
of the weak splice site sequences that border exon 13A. The
flanking intronic sequences were also highly conserved.
Upstream of exon 13A, beginning at nt 166, there is a putative
branch point sequence ACTTAC, containing the branch point A,
predicted to specify the inclusion of exon 13A (Yeowell and
Walker, 1999; Gooding et al., 2006). This is closely followed by
a highly conserved polypyrimidine tract (PPT), which includes
binding sites for the polypyrimidine tract binding protein (PTB;
Carstens et al., 2000). PTB has been shown to act principally as
a mediator of exon silencing and thus PTB binding within the
PPT could potentially result in the loss of exon definition and
exclusion of exon 13A. The 63bp sequence of the alternatively
spliced exon 13A and the nonconsensus splice sites of exon
13A are very highly conserved across species. Downstream of
exon 13A, between nts 264 and 297, is a well-conserved 33bp
U-rich element which is very similar to binding sites for the
regulatory TIA proteins (Le Guiner et al., 2001). TIA protein
binding to similar elements has been shown to enhance
the use of upstream weak 50 splice sites facilitating inclusion
of the alternatively spliced exon. From the phylogenetic analysis
we were able to identify most of the conserved intronic
regulatory elements to be included in the LH2 minigene.
Design of an LH2 minigene and successful transfection into (a)
skin fibroblasts and (b) HEK293 cells
To study the effect of cis-elements and trans-acting factors on
the regulation of LH2 splicing, we have designed an LH2
minigene. Based on the identification of highly conserved
sequences flanking the alternately spliced exon 13A (Fig-
ure 1), we amplified a 353 bp LH2 genomic fragment that
included 160bp of intron 13 (which contained the branch
point and the PPT), the alternatively spliced exon 13A
(63 bp), and 130bp of intron 13A (which contained the
putative TIA binding site). This LH2 fragment was inserted in
the multiple cloning site of a two-exon, one-intron adeno-
virus-derived splicing plasmid pI-12 (Figure 2a). This plasmid,
adapted for eukaryotic expression, is derived from pcDNA3
(Invitrogen), and includes an XbaI/ClaI cloning site, an
efficient immediate early cytomegalovirus promoter, and a
bovine growth hormone polyadenylation site (poly A;
Carstens et al., 1998).
Transfection of LH2 minigene into neonatal fibroblasts.
Following transfection of the LH2 minigene into human
neonatal skin fibroblasts, we analyzed the LH2 splicing
pattern in transiently transfected cells and from stables
isolated using G418 selection. RNA was isolated as described
in Materials and Methods and the LH2 transcript ratio was
analyzed by reverse transcription RT–PCR (Figure 2b). Using
specific sets of primers for minigene splicing (p1, p2) and
endogenous splicing (p3, p4), the long and short forms of LH2
were amplified for each set, and following gel electrophor-
esis, the transcript ratio was calculated as described in
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Materials and Methods. In stables, the ratio of long to short in
the LH2 minigene splicing was 2 to 1, and in the endogenous
LH2 splicing the ratio was 8 to 1. This pattern was unchanged
in transient transfections (data not shown).
Transfection of LH2 minigene into HEK293 cells. The LH2
minigene was also transfected into HEK293 cells and RNA
was isolated from transients and stables. Following amplifica-
tion of RNA isolated from transient transfections by RT–PCR
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Figure 1. Endogenous lysyl hydroxylase 2 alternate splicing pattern and conservation analysis of LH2 genomic sequence. The top panel (not drawn to scale) is
a diagram of the region, which includes exon 13A and flanking intronic sequences thought to be involved in the regulation of LH2 splicing. The splicing pattern
of LH2 is represented by the dotted lines (in which exon 13A is retained to give the long form of LH2) and the solid line (in which exon 13A is excluded to give
the short form of LH2). The nonconsensus 50 splice in intron 13A is flanked downstream by a U-rich region. Upstream regulatory sequences include the branch
point BP and polypyrimidine tract (PPT). The vertical arrows represent the sites of incorporation of the XbaI and ClaI cloning sites, respectively. The conservation
panel below represents the alignment of exon 13A and proximal intron sequences from six species, H. sapiens (human), C. familiaris (dog), Monodelphis
domestica (opossum), M. musculus (mouse), R. norvegicus (rat), and G. gallus (chicken), using the MacVector Clustal W Alignment function (Higgins et al.,
1996). The highly conserved regions are boxed. For simplicity, the numbering begins at the first base shown. The location of exon 13A (195–257) is shown by
horizontal arrows. The branch point in intron 13 begins at nt 166 and contains the invariant A at nt 170, marked by an asterisk. PPT beginning at nt 175 is
represented by the dots and the 33 bp downstream U-rich region beginning at nt 264 is represented by the dashes. The highly conserved 50 splice site of intron
13A is underlined. Vertical arrows depict the location of the incorporated upstream XbaI and downstream ClaI sites used in the cloning of the LH2 minigene.
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and gel electrophoresis, the splicing ratio of long to short LH2
was 1 to 2 in both minigene and endogenous (data not
shown). In stables, the long to short ratio in LH2 minigene
splicing was 1 to 0.8, which differed slightly from the
endogenous splicing ratio of 1 to 2 (Figure 2c). From these
experiments, we concluded that the minigene sufficiently
recapitulated the splicing patterns of the endogenous gene to
provide a valuable tool to analyze the alternate splicing of LH2.
Modification of weak 5’ splice site of intron 13A to consensus
sequence enhances exon definition and shows functionality of
the minigene
We changed the weak 50 splice site of exon 13A to a
consensus splice site using site-directed mutagenesis and
showed that in transfected HEK293 cells, only a single long
LH2 transcript (in contrast to expression of both transcripts in
the unmodified minigene) was expressed in the consensus
minigene (data not shown). This emphasized the importance
of the weak 50 splice site in the regulation of the splicing ratio
of LH2 (long) to LH2 (short). Furthermore this experiment
demonstrated the viability of the minigene, and confirmed its
value as a tool to study the alternate splicing of LH2.
Depletion of TIA factors in mouse embryonic fibroblasts and
HEK293 cells reduces expression of LH2 (long)
The highly conserved U-rich region of RNA located down-
stream from the weak 50 splice site of the alternate exon 13A
(shown in Figure 1) provides a putative binding site for TIA
factors predicted to promote inclusion of the weak alternate
exon 13A. To examine the regulatory effect of TIA factors on
LH2 splicing, we utilized two independent techniques to
deplete TIA-1 and TIAL1.
Ratio of LH2 (long) to LH2 (short) is decreased in embryonic
fibroblasts from TIA-1/ and TIAL1/ mice. The LH2
minigene was transiently transfected into murine embryonic
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Figure 2. Design of the LH2 minigene; transfection of LH2 minigene into neonatal fibroblasts and HEK293 cells shows similar pattern of minigene versus
endogenous splicing. (a) The minigene (upper section) was designed such that the LH2 sequence containing the alternatively spliced exon 13A is inserted at the
XbaI/ClaI site between the strong consensus 50 and 30 splice sites of the adenoviral splicing plasmid pI-12 (Carstens et al., 1998). The branch point (BP) and the
polypyrimidine tract (PPT) are shown in the sequences of the adenoviral (AD) intron and intron 13 of LH2 upstream from the 30 splice sites of their respective
exon/intron junctions. The U-rich sequence is shown downstream of exon 13A. U and D represent the adenoviral exons upstream and downstream of the
inserted minigene sequence, respectively. The alternate splicing events that either exclude exon 13A (solid line) or include exon 13A (dotted line) are shown in
the LH2 minigene (upper section) and in the endogenous LH2 gene (lower section), respectively. In the upper panel, arrows show the T7 and SP6 primer sites
(p1, p2) for amplification of the spliced LH2 minigene transcripts. In the lower panel, arrows show location of the primers (p3, p4) in exons 13 and 14 in the LH2
gene (outside of the minigene sequence) used to amplify the endogenous spliced transcripts of LH2. (b) The splicing patterns of RT–PCR products amplified from
RNA isolated from stables following transfection of the LH2 minigene into neonatal fibroblasts are shown for minigene and endogenous. CON represents
nontransfected cells. Locations of LH2 (long) and LH2 (short) are shown by the arrows. The sizes of these amplified, alternatively spliced transcripts for LH2
(long) and LH2 (short) are 299 and 236 bp (minigene) and 253 and 190 bp (endogenous), respectively. The molecular weight markers are shown in each gel.
(c) The panel shows the splicing pattern of LH2 (long) and LH2 (short) as described in (b) following isolation of stables after transfection of the LH2 minigene into
HEK293 cells. Minigene and endogenous splicing patterns are as shown. The sizes of the LH2 transcripts are described in (b).
www.jidonline.org 1405
HN Yeowell et al.
TIAs Regulate Fibrosis-Linked LH2 (Long)
fibroblasts derived from TIA-1/ and TIAL1/ mice that had
been previously characterized as lacking TIA-1 and TIAL1,
respectively (Beck et al., 1998; Li et al., 2002). The pattern of
endogenous and LH2 minigene splicing was examined by
RT–PCR. As shown in the endogenous splicing in Figure 3a
(which is unaffected by minigene transfection), there was a
striking increase in LH2 (short) in TIAL1/ compared with
wild type. This resulted in a significantly decreased ratio of
(long) to (short) LH2 compared to wild type as shown in the
bar graph. Although there was a minimal effect in the
TIA-1/ knockout MEFs, this result was not entirely
unexpected in view of reports that these proteins have
redundant and subtly distinct cellular roles, thereby account-
ing for the variability of the individual knockouts (Izquierdo
and Valcarcel, 2007). However amplification of the LH2
minigene transcripts did show a decrease in the ratio of LH2
(long) to LH2 (short) in the TIA-1/ knockout MEFs
compared to wild type, an effect that was replicated in the
TIAL1/ MEFs (Figure 3b).
Ratio of LH2 (long) to LH2 (short) is decreased in HEK293
cells knocked down for TIA-1 and TIAL1, either singly or in
combination. Given that TIA-1 and TIAL1 show functional
redundancy, we sought to examine exon 13A inclusion in
cells depleted of both. Unfortunately double TIA-1//
TIAL1/ mice are nonviable and consequently no MEFs
depleted of both factors are available. Therefore we used a
second method of examining the regulation of LH2 splicing
under conditions in which both forms of TIA were depleted.
To do this, we used siRNAs against TIA-1 and TIAL1 both singly
and in combination which, as shown in theWestern blot (Figure
4a), gave an effective knockdown. A nonfunctional siRNA (C2)
was transfected as a negative control. In the endogenous
transcripts, LH2 (long) was reduced, compared with control, in
both TIA-1 and TIAL1 knockdowns and almost completely
eliminated in the double knockdown (Figure 4b). The decreased
ratio of splicing of LH2 (long) to LH2 (short) is shown in the
corresponding bar graph, with a value that approached zero for
the double knockdown. The pattern of splicing in the LH2
minigene was measured under the same set of conditions and
showed a similar trend compared to the endogenous splicing
(Figure 4c). The levels of LH2 (long), which are higher in the
minigene than in the endogenous transcript, were decreased by
60% in the double knockdown. An intermediate effect on the
reduction of the LH2 (long) to LH2 (short) ratio was observed in
the cells knocked down individually for TIA-1 and TIAL1.
Although, as might be predicted from the results with the TIA-
1/ and TIAL1/ mice, there was some variability between
endogenous and minigene in the effects of depletion of these
individual factors on the LH2 (long) to LH2 (short) ratio, the
importance of this data is that decreased levels of TIAs, either
singly or in combination, result in significantly reduced levels of
LH2 (long). These results on the effect of decreasing TIAs by
both knockdowns and in knockouts show clearly that the TIA
proteins are required for efficient inclusion of LH2 exon 13A.
Overexpression of TIA-1 and TIAL1 decreases LH2 (short) and
upregulates expression of LH2 (long) following transfection of
the minigene into HEK293 cells
To examine the effect of increased levels of TIA proteins on
the regulation of LH2 splicing, TIA-1 and TIAL1 were
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Figure 3. Ratio of LH2 (long) to LH2 (short) is decreased in TIA-1 and TIAL1
knockout mouse embryonic fibroblasts.Wild-type mouse embryonic fibroblasts
(MEFs (WT)) and TIA-1/ and TIAL1/ knockout MEFs were transfected with
1ug of LH2 minigene and the patterns of endogenous and minigene LH2
splicing in nontransfected (C) and transfected (T) fibroblasts were measured in
triplicate by RT–PCR of isolated RNA as shown in panels (a) and (b). Panel (a)
shows the pattern of endogenous LH2 splicing in TIA-1/ and TIAL1/
knockout MEFS compared with normal MEFS (WT). Gel electrophoresis of
representative samples from triplicate PCRs, shown as control (nontransfected)
(C) and transfected (T), are quantitated as the ratio of LH2 (long) to (short) in the
bar graph below. (Note: endogenous splicing is unaffected by minigene
transfection.) Panel (b) shows RT–PCR results of the pattern of LH2 splicing in the
LH2 minigene in the knockout and wild-type fibroblasts (T) compared with
nontransfected MEFS (C). Results from wild-type MEFS (WT) and TIA-1/ and
TIAL1/ knockouts are tabulated as the ratio of LH2 (long) to (short) in the bar
graph below. Molecular weight markers shown on the left of the gel, together
with a PCR blank (Bl). Data are presented as mean±SD.
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overexpressed in HEK293 cells by transfecting increasing
amounts of the expression plasmid together with 100 ng
of LH2 minigene. The Western blot (Figure 5a) confirmed
that the level of TIA-1 was increased with increasing amounts
of the respective overexpression plasmids. TIAL1 was
increased in a similar pattern (data not shown). Over-
expression of TIA-1 resulted in a significant decrease
in the level of LH2 (short) accompanied by an increase in
LH2 (long) in the minigene (Figure 5b). A similar result was
obtained for TIAL1 (data not shown). Interestingly we
did not observe such a significant effect of overexpression
of the TIAs on the endogenous splicing pattern of LH2 (data
not shown).
Overall, these results from two independent sets of
experiments in which TIAs were either absent or significantly
reduced (Figures 3 and 4) and one experiment in which
TIAs were overexpressed (Figure 5) demonstrated that the TIA
proteins are both required and able to facilitate inclusion of
exon 13A and hence expression of the long form of LH2.
Whereas absence or a significant decrease in these TIA
factors resulted in decreased expression of LH2 (long),
overexpression of the TIAs enhanced inclusion of exon 13A
to give increased expression of the long form of LH2. Thus we
conclude that the TIA proteins are required for the efficient
inclusion of the additional exon.
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Figure 4. siRNA knockdowns of TIA-1 and TIAL1 both singly and in
combination in HEK293 cells decrease the ratio of LH2 (long) to LH2 (short).
The TIA factors were knocked down using specific siRNAs by standard
methodology as described. (a) The panel shows results from a Western blot
analysis as described in Materials and Methods in which membranes were
probed with specific antibodies (a) to TIA-1 and TIAL1 and, as a loading
control, antibody to CA150. (b) The panel shows the RT–PCR pattern of
endogenous splicing, in triplicate, following the single and double
knockdowns of TIA-1 and TIAL1 by siRNAs, compared with the transfection
of a nonfunctional C2 siRNA (CON) as described in Materials and Methods.
Quantitation of the LH2 (long) to (short) ratio is shown in the bar graph. (c)
The panel shows the effect of the siRNA knockdowns on the RT–PCR pattern
of splicing of transfected LH2 minigene in triplicate. The ratio of LH2 (long) to
(short) in the minigene splicing is quantitated in the bar graph below. Data are
presented as mean±SD (in some cases the error bars are too small to be
visualized).
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Figure 5. Overexpression of TIA-1 increases LH2 (long) and decreases LH2
(short) in the LH2 minigene transfected into HEK293 cells. (a) Western blot
analysis was carried out as described in Materials and Methods and confirms
the overexpression of TIA-1 following transfection of TIA-1 plasmid at
amounts of 500, 1,000, and 2,000 ng into HEK293 cells. aGAPDH was used
to confirm equivalence of loading. (b) This panel shows, in triplicate, the
effect of transfection of different amounts of a plasmid overexpressing TIA-1
on the pattern of minigene splicing of LH2 (long) and LH2 (short) in HEK293
cells. Results from RT–PCR of isolated RNA are shown in the bar graph below.
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In scleroderma fibroblasts, the increased level of LH2 (long) is
decreased by siRNA knockdown of TIAs
Data from our experiments as well as from other laboratories
demonstrates an increase in the levels of LH2 (long) in cells
derived from scleroderma patients. As our data suggested a
significant role for TIA factors in the regulation of LH2
splicing, our next question was whether the increased LH2
(long) in cells from scleroderma patients could be decreased
by a knockdown of TIA proteins. Initially, we isolated RNA
from a scleroderma cell line and a matched control and
measured the levels of LH2 (long) by real-time PCR, using
primers as described (van der Slot et al., 2003). As previously
reported in the literature (van der Slot et al., 2003, 2004), we
observed higher levels of LH2 (long) in the scleroderma
fibroblasts than in normals (4.5-fold higher; data not shown).
To determine the effect of reducing TIA levels on the
scleroderma-associated increased expression of LH2 (long),
scleroderma fibroblasts together with a matched control were
transfected in a two-hit protocol with a combination of siRNA
duplexes against TIA-I and TIAL1. RNAs were isolated and
amplified by RT–PCR to analyze the splicing pattern of
endogenous LH2 transcripts. As shown by gel analysis in
Figure 6a, a dramatic decrease in LH2 (long) and an increase
in LH2 (short) was demonstrated in the scleroderma cells in
which TIA-1 and TIAL1 had been knocked down, compared
with cells transfected with a nonspecific siRNA duplex C2.
These results, expressed as the ratio of LH2 (long) to LH2
(short), are shown in Figure 6b and demonstrate that this ratio
is reduced by over 80% in the TIA knockdowns. The double
TIA knockdown in the matched control fibroblasts resulted in
an identical reduction in the ratio of LH2 (long) to LH2 (short)
compared with the scleroderma fibroblasts (data not shown).
The mock-transfected fibroblasts from both scleroderma and
matched control essentially expressed only LH2 (long), as we
have previously reported in nontransfected human skin
fibroblasts (Walker et al., 2005).
As the decreased levels of TIA-1 and TIAL1 were too low
to be detected by Western blots, the knockdown of the
individual TIAs was confirmed by real-time PCR (Figure 6c).
This showed that the double knockdown reduced TIA-1
mRNA levels by 60% and TIAL1 levels by 80% compared
with their respective control.
Overall, these results have identified a potential target for
decreasing the expression of the fibrosis-associated LH2
(long).
DISCUSSION
This article describes the first identification of factors (TIA-1
and TIAL1) that appear to regulate the expression of the
alternatively spliced long form of LH2 that is increased under
fibrotic conditions. Earlier, our laboratory identified the long
form of LH2, which includes an additional 63 bp exon 13A
(Yeowell and Walker, 1999) and is shown to be expressed in
all tissues examined so far. Our interest in studying the
regulation of expression of the long form of LH2 has been
heightened in light of several reports (van der Slot et al.,
2004, 2005; Wu et al., 2006) that the long transcript of LH2 is
increased in scleroderma and several other fibrosis-related
disorders. The mechanism of regulation of the splicing
pattern of LH2, that may provide useful control points for
the increased expression of LH2 (long), has the potential to
provide a crucial breakthrough in the treatment of certain
fibrosis-related conditions. In the current study, we have
designed an LH2 minigene that recapitulates the endogenous
splicing pattern. The manipulation of this minigene has
allowed us to identify factors such as TIAs, nuclear binding
proteins known to enhance the inclusion of a weak exon, that
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Figure 6. A combined siRNA knockdown of TIA-1 and TIAL1 in scleroderma
fibroblasts effectively decreases LH2 (long) and increases LH2 (short).
RT–PCR was performed on RNA isolated from scleroderma cells transfected in
a two-hit protocol with combined siRNA duplexes against TIA-1 and TIAL1
and, as control, a nonfunctional siRNA (C2) as described in Materials and
Methods. Panel (a) shows, in triplicate, the combined effect of TIA-1 and
TIAL1 siRNA knockdowns on the pattern of endogenous LH2 splicing in
scleroderma cells compared with mock-transfected cells (C2 siRNA). The bar
graph in panel (b) shows the ratio of LH2 (long) to LH2 (short) based on
RT–PCR. As the decreased levels of the TIA factors were too low to be clearly
detected by Western blot analysis, real-time PCR was used to confirm the
knockdown of both TIA-1 and TIAL1 compared with control (C2 siRNA) as
shown in panel (c).
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can regulate the alternative splicing pattern of LH2. Using
both knockdown and overexpression methods, we have
demonstrated that TIAs are required for expression of LH2
(long). Application of these results to the regulation of the
overexpressed LH2 (long) transcript in scleroderma fibro-
blasts has shown that decreasing TIA factors reduces the ratio
of LH2 (long) to LH2 (short) by over 80% of the level in
untreated cells. This effect may offer an opportunity to
intervene in the overproduction of LH2 (long) associated with
fibrotic conditions.
The pattern of alternative splicing in the LH2 gene appears
to contribute significantly to fibrotic conditions such as occur
in scleroderma. One of the major characteristics of fibrosis is
an excessive accumulation of collagen, which is the result of
increased collagen synthesis and of decreased protease
activity responsible for collagen degradation (Trojanowska
et al., 1998). However, it should be noted that there is no
direct evidence that increased pyridinium cross-link content
in soft tissue causes increased resistance to proteolysis and
this has yet to be verified. The pattern of collagen cross-
linking is changed under fibrotic conditions, with an increase
in the level of Pyr cross-links (Istok et al., 2001). The increase
in Pyr cross-links (van der Slot et al., 2005) and the precursor
bifunctional cross-links formed via the hydroxyallysine route
(Brinckmann et al., 2005; Wu et al., 2006) that are observed
under certain fibrotic conditions (van der Slot et al., 2004),
suggests an association with the recently reported increase in
LH2 (long) under these conditions. In addition, a recent
report describes an increase in LH2 (long) in scar formation in
deep dermal wounds (Ulrich et al., 2007). In turn, this is
linked to the increased Pyr collagen cross-links observed in
scleroderma. In view of the fact that Pyr cross-links can be
derived only from telopeptide hydroxylysines, these studies
provide indirect evidence that LH2 (long) may be a
telopeptide LH (van der Slot et al., 2004). Recently, in a
recombinant study, LH2 (long) was shown to have collagen
telopeptide hydroxylase activity in addition to acting as a
helical hydroxylase (Takaluoma et al., 2007), but the
collagen domain specificity of LH2 (short) has not been
measured and is currently under investigation (H. Yeowell
and L. Walker, unpublished results).
There are striking differences in the splicing pattern of LH2
between tissues. Our previous work on the regulation of the
alternative splicing of LH2 described the effect of cyclohex-
imide on the relative expression of LH2 (long) to LH2 (short) in
both skin fibroblasts (in which the long LH2 transcript is
predominantly expressed) and HEK293 cells (in which both
short and long transcripts of LH2 are almost equally expressed;
Walker et al., 2005). In both cell lines after 24hours of
cycloheximide treatment the ratio of the long to short LH2
transcripts was significantly decreased, indicating that expres-
sion of LH2 (long), and therefore inclusion of the additional
exon, required a newly synthesized protein(s) that is suppressed
by cycloheximide. This is supported by our current study
demonstrating that the TIA-binding proteins are required for the
inclusion of exon 13A and expression of LH2 (long). This study
provides the first description of the involvement of a family of
trans-acting factors in the regulation of LH2 splicing, and it
appears likely that additional groups of proteins, for example
the PTB (Wagner and Garcia-Blanco, 2002), may also play a
significant regulatory role.
One application of our current results that TIAs are required
for expression of LH2 (long) is that they offer a potential method
for controlling the ratio of LH2 (long) to LH2 (short) transcripts
that changes in fibrotic conditions such as scleroderma and
keloids, and consequently may play a significant role in this
type of disorder. Scleroderma is complex in that it is not a single
disease but a set of related disorders with similar symptoms. The
major types are localized scleroderma, which includes general-
ized and linear morphea and only affects the skin, and systemic
sclerosis, which is a life-threatening autoimmune disease that is
characterized by the presence of specific autoantibodies and
fibrosis of the skin and major internal organs. Although many
factors contribute to the pathogenesis of scleroderma (Troja-
nowska et al., 1998), there have been several recent reports that
LH2, and more specifically LH2 (long), is increased in both skin
and fibroblasts from scleroderma patients (van der Slot et al.,
2004, 2005; Wu et al., 2006). Further evidence to support the
linkage between increased levels of LH2 (long) and the
overaccumulation of collagen that is a characteristic of fibrosis
is provided by reports that increased expression of LH2 (long) is
associated with increased collagen synthesis (Mercer et al.,
2003; Wu et al., 2006). The regulation of the splicing pattern of
LH2 therefore presents an alternative avenue of exploration for a
potential treatment of scleroderma. Several diseases have been
linked to alternative splicing and have opened up avenues
leading to possible therapies (Garcia-Blanco et al., 2004). Some
examples include cystic fibrosis, in which mutations in either
cis- or trans-acting regulatory sequences cause aberrant splicing
leading to abnormal protein production. Correction of this
abnormal splicing therefore offers a potential therapy (Rowntree
and Harris, 2003). One example of regulating gene expression
directly is given in the treatment of spinal muscular atrophy in
which inclusion of exon 7 in SMN2 transcripts is facilitated to
give an enhanced expression of SMN2 (Srivastava et al., 2001).
The strong influence of TIA factors on the regulation of
splicing of LH2 encouraged us to look at the effect of
decreasing TIAs on the overexpression of LH2 (long) in
scleroderma fibroblasts. Overall increases in LH2 in scler-
oderma cells have also been reported (van der Slot et al.,
2003; Brinckmann et al., 2005) and a microarray study on
scleroderma skin showed increased levels of LH2 (Whitfield
et al., 2003). The effective knockdowns of TIA-1 and TIAL1 in
this scleroderma fibroblast cell line resulted in a dramatic
reduction in the ratio of LH2 (long) to LH2 (short) compared
with mock-transfected cells. These exciting results, showing
that LH2 (long) is significantly reduced by decreasing levels
of the TIA proteins, pave the way for an alternative approach
to scleroderma treatment that involves manipulation of the
LH2 alternative splicing pathway so that the expression of
LH2 (long) is reduced.
In this study we present the first report on the mechanism
of regulation of the alternate splicing of LH2. We have
demonstrated that decreased levels of TIA factors result in a
decrease of the long form of LH2. Application of this result to
scleroderma cells that are characterized by significantly
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increased levels of LH2 (long) has shown that decreased TIA
factors markedly reduce levels of LH2 (long). This approach
may therefore provide an opportunity to intervene in the
overproduction of LH2 (long) that is associated with fibrotic
conditions such as scleroderma and keloids. Moreover, this
prototype LH2 minigene (and its derivatives that are currently
being constructed) (P. Seth and H. Yeowell, unpublished
results), which enables us to study the effect of both cis- and
trans-acting factors on the regulation of LH2 splicing, may be
used to examine the effect of other regulatory proteins such as
PTB that may also play a significant role in the regulation of
LH2 splicing.
MATERIALS AND METHODS
Cell culture
HEK293T cells and MEFs (Beck et al., 1998; Piecyk et al., 2000)
were cultured in DMEM (Gibco-BRL, Carlsbad, CA) supplemented
with 10% fetal bovine serum (HyClone, Logan, UT). Neonatal
foreskin fibroblasts (kindly provided by Dr J. Zhang, Duke
Dermatology, DUMC) were cultured in DMEM supplemented with
10% fetal bovine serum. A scleroderma cell line and a matched
control from our cell bank were cultured under similar conditions.
The Institutional Review Board of Duke University Health System
approved all the described studies. The study was conducted
according to Declaration of Helsinki Principles.
Minigene design
The highly conserved 353bp LH2 minigene sequence that includes
160bp of intron 13, the alternatively spliced exon 13A (63bp), and
130bp of intron 13A was amplified from genomic DNA incorporating
XbaI and ClaI restriction sites at the 50 and 30 ends, respectively. The
sequence of the cloning primers was as follows: forward primer;
CTAGT/CTAGAttgtgtgtgctataagctttgc (with XbaI restriction site under-
lined and intron 13 sequence in lower case) and reverse primer; CCAT/
CGATacagatgactgatgaaaatcaac (with ClaI restriction site underlined
and intron 13A sequence in lower case). This amplified minigene
sequence was digested with XbaI/ClaI and ligated to pI-12 vector with
compatible ends (Carstens et al., 1998). The LH2 minigene was
inserted in the multiple cloning site of pI-12 flanked by the adenovirus-
derived upstream and downstream exons with strong splice sites.
Following cloning and amplification, the accuracy of the construct was
checked by restriction digest and sequence analysis.
Transfection of LH2 minigene into neonatal fibroblasts, mouse
embryonic fibroblasts and HEK293 cells
The functionality of the LH2 minigene was validated by transfecting
the LH2 minigene into neonatal fibroblasts and HEK293 cells, and
measuring the levels of alternatively spliced LH2 transcripts derived
from either the minigene or the endogenous LH2 transcripts in both
transients and stables. The transfections were carried out as
previously described (Carstens et al., 1998).
Analysis of LH2 (long)/(short) expression in neonatal
fibroblasts, mouse embryonic fibroblasts, and HEK293 cells
Semiquantitative RT-PCR. The cDNA was prepared from 1mg of
the isolated RNA using the iScript cDNA synthesis kit (Bio-Rad,
Hercules, CA), according to manufacturer’s protocol. The endogen-
ous cDNA was amplified using primers based on exons 13 and 14 to
give fragments of 253 and 190bp of LH2 (long) and LH2 (short),
respectively as previously described (Walker et al., 2005). Standard
T7 and SP6 promoter primers were used for amplification of the
transfected minigene to give fragments of 299 and 236bp of LH2
(long) and LH2 (short), respectively. The products of this PCR were
analyzed as previously described (Walker et al., 2005). The net
intensity of each band was calculated and expressed as the ratio of
LH2 (long) to LH2 (short).
Real-time PCR. The isolated RNA was reverse-transcribed with
MMLV RT (Invitrogen) using random hexamers. The PCR was then
performed in a Bio-Rad iCycler using the iQ SYBR Green Supermix
(Bio-Rad). The details of the primers used for the real time PCR are as
follows: (for LH2 (long) the primers have been described previously
(van der Slot et al., 2003)); for TIAL1, forward primer: TGATAACA
GAGCATACAAGCAATG and reverse primer: CCCATTCATAG
CAGCTAATGCAGC were used; for TIA-1, forward primer: ATGCC
CAAGACTCTATACGTCGGT and reverse primer: ATGAAACTCCA
CAAAACAATAGGG were used. All the real-time PCR products were
normalized to the 18 s rRNA controls. The PCR primers for 18S rRNA
were as previously described (Walker et al., 2005).
Mutation of minigene to a consensus 5’ splice site and analysis
In our minigene construct, we mutated the weak 50 splice site of intron
13A (AGgtgtta) to the consensus 50 splice site in which the tta was
changed to agt to match that of the adenoviral vector (AGgtgagt) using
the QuikChange II SDM kit (Stratagene, Cedar Creek, TX). The pI-12-
LH2 minigene plasmid was amplified by PCR using two complemen-
tary oligonucleotide primers that introduce the change of tta to agt as
shown: 50GCtcagccccccaaag/gtgagttttttacttattta and 30taaataagtaaaaaa
ctcac/CTTTGGGGGGCTGAGC. Following clonal selection and iso-
lation of DNA, the plasmid was sequenced to confirm successful
mutagenesis. The plasmid was transfected into HEK293 cells, and RNA
was isolated from stables. The LH2 splicing pattern of the minigene
transcripts was analyzed by semiquantitative RT-PCR and products
were resolved on 3% agarose (data not shown).
Two-hit siRNA knockdown of TIA-1 and TIAL1 binding proteins
HEK293 and scleroderma fibroblasts were transfected with siRNA
duplexes as described (Baraniak et al., 2006). The siRNA target
sequences were selected as follows: TIA-1, 50-GGAAGUCAAAGU
GAAUUGG-30; TIAL1, 50-GGAGGUCAAAGUAAACUGG-30. The
siRNA duplexes were purchased from Dharmacon (Lafayette, CO).
Overexpression experiments
Overexpression plasmids pMT2-TIA-1 and pMT2-TIAL1 were a kind
gift from Paul Anderson. The overexpression plasmids were intro-
duced in HEK293 cells using Lipofectamine (Invitrogen; Carlsbad, CA)
according to the manufacturer’s instructions. The transfections were
performed as described earlier. The cells were harvested 48hours
after transfection, before isolation of RNA and proteins.
Isolation of proteins for western blot analysis of TIA expression
The proteins were isolated from cells by first washing the cells with
phosphate-buffered saline and then scraping them off the wells using
a cell scraper and resuspending them in phosphate-buffered saline.
They were then lysed by either a 3X freeze-thaw method (Baraniak
et al., 2006) or by resuspending them in cold lysis buffer containing
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1% NP-40. Total protein was quantified by Bradford assay (Bradford,
1976). For the Western blot analysis, equal amounts of total protein
were run on 7.5% SDS–PAGE, transferred to polyvinylidene fluoride
membranes (Millipore, Billerica, MD) and probed with the appro-
priate primary and secondary antibodies as described (Baraniak
et al., 2006).
Antibodies
Goat polyclonal anti-TIA-1 and goat polyclonal anti-TIAL1 were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Polyclonal antibodies directed at human CA150 and GAPDH were
used as loading controls (Baraniak et al., 2006).
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